文献速递气道管理

高流量鼻氧合而非通气:是时候停止屏息以待了

High-flow nasal oxygenation, not ventilation: time to stop holding our breath.
PubMed 文献 · Br J Anaesth · 2025-12-15

本文剖析高流量鼻氧合(HFNO)的现有证据,讨论其有限的通气能力,并结合指南与新兴研究提出实践建议。累积证据表明HFNO不能清除二氧化碳,成人和儿童在广泛流量范围内均出现动脉二氧化碳蓄积,提示高碳酸血症风险。建议将THRIVE更名为apnoeic HFNO,强调多模式二氧化碳监测和选择性使用通气辅助。

要点

  • HFNO不能有效清除CO2,成人和儿童均出现动脉CO2蓄积。
  • 建议将THRIVE更名为apnoeic HFNO,强调其氧合而非通气功能。
  • 临床需多模式监测CO2,必要时选择性使用通气辅助。

核心结论

  • HFNO不具备有效通气能力,不能清除二氧化碳,存在高碳酸血症风险。
  • 应停止使用THRIVE这一暗示通气交换的术语,改为apnoeic HFNO。

主要发现

  • 成人和儿童在广泛流量范围内均出现一致的动脉二氧化碳蓄积。
  • HFNO的高碳酸血症风险对血流动力学和神经功能有重要临床影响,尤其在高危人群。

临床怎么用

  • 麻醉医生应使用apnoeic HFNO替代THRIVE术语。
  • 临床应用中应强调多模式二氧化碳监测。
  • 必要时选择性使用通气辅助装置。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

High-flow nasal oxygenation (HFNO) has gained popularity in tubeless upper airway surgery owing to its ability to maintain oxygenation during apnoea. We dissect current evidence on HFNO, discuss its limited ventilatory capability, and integrate established guidelines with emerging research to propose practical considerations in its use. Despite early claims of ventilatory benefit, accumulating evidence suggests that HFNO does not clear carbon dioxide. In both adults and children, consistent arterial carbon dioxide accumulation across a wide range of flow rates highlights the risk of hypercapnia. This has important clinical implications for haemodynamic and neurologic function, especially in high-risk populations. Anaesthetists and the scientific community should replace the term 'transnasal humidified rapid-insufflation ventilatory exchange (THRIVE)' with 'apnoeic high-flow nasal oxygenation (apnoeic HFNO)', with an emphasis on multimodal carbon dioxide monitoring the selective use of ventilatory adjuncts when required.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Wen GA, Aziz MF. High-flow nasal oxygenation, not ventilation: time to stop holding our breath. Br J Anaesth. 2025. PMID: 41402219. doi:10.1016/j.bja.2025.11.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。